• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2400278 静注人免疫球蛋白 human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-10-23 Hualan Biological Engineering Inc view
CYSB2400277 静注人免疫球蛋白 human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-10-23 Hualan Biological Engineering Inc view
CYSB2400267 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-10-10 Guangdong Shuanglin Bio-Pharmacy Co Ltd view
CYSB2400260 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) Supplementary Application 2024-09-26 Shanxi Kangbao Biological Product Co Ltd view
CYSB2400253 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-09-26 Sinopharm Kunming Blood Products Co Ltd view
CYSB2400252 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-09-26 Sinopharm Kunming Blood Products Co Ltd view
CXSL2400412 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.2) New Drug Application 2024-06-26 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2400114 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-05-15 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2400096 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-04-25 Green Cross China Biological Products Co Ltd view
CYSB2400097 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-04-25 Green Cross China Biological Products Co Ltd view
CYSB2400098 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-04-25 Green Cross China Biological Products Co Ltd view
CXSL2400234 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) New Drug Application 2024-04-16 Sichuan Yuanda Shuyang Pharmaceutical Co Ltd view
CYSB2400062 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-03-05 China Resources Boya Bio-pharmaceutical Group Co Ltd view
CYSB2400061 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-03-01 China National Pharmaceutical Group Guizhou Biopharmaceutical Co Ltd view
CYSB2400058 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-03-01 China National Pharmaceutical Group Guizhou Biopharmaceutical Co Ltd view
CYSB2300149 静注人免疫球蛋白(10%) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2023-08-02 Guangdong Shuanglin Bio-Pharmacy Co Ltd view
CYSB2300148 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2023-07-28 Xinjiang Deyuan Biological Engineering Co Ltd view
CXSL2200603 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) New Drug Application 2022-12-16 Guangdong Danxia Biology Pharmcy Co Ltd view
CXSL2200604 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) New Drug Application 2022-12-16 Guangdong Danxia Biology Pharmcy Co Ltd view
CYSB2200240 静注人免疫球蛋白(10%) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-10-10 Guizhou Taibang Biological Products Co Ltd view